Search results
Glycostem launches pivotal oncology trial with evolved naked natural killer cells
Nature· 16 hours agoGlycostem’s pivotal trial is planned to start in late 2020 and will involve five European countries, eight clinical trial centers and 33 patients with minimal residual disease (MRD) positive ...
A Primer to proliferation - Nature Cell Biology
Nature· 16 hours agoBinary division of cells is one of the most basic features of life but also one of its biggest miracles. For a cell to divide it has to replicate its genome and to equally distribute it to both ...
Balancing drug availability and patient safety - Nature Reviews Gastroenterology & Hepatology
Nature· 17 hours agoOver the past 7 years, the US FDA has been under attack from numerous directions over its mission “To promote public health by promptly and efficiently reviewing clinical research and taking ...
Spherical Aberration of the Eye - Nature
Nature· 17 hours agoIf the pupil be now progressively covered from above, the rays passing through the middle and upper part of the pupil will be cut off, so that those passing through the lower part of the pupil ...
The Butterflies of Europe - Nature
Nature· 17 hours agoThe whole of the species (and some prominent varieties, &c.) inhabiting Europe proper will occupy about twenty monthly parts, each containing sixteen pages of text and four coloured plates.
Improving diagnostic rates for rare diseases by streamlining genomic interpretation
Nature· 17 hours agoGenetics defines nearly 80% of all rare diseases. Despite readily available genome sequencing, many people with a rare disease experience diagnostic delays, or are never properly ...
Southgate has one more step on road to England redemption: the Euro 2024 final
ESPN.co.uk· 18 hours agoIt's been an unusual environment to operate in." One friend of Southgate has told ESPN that the one...
The Government’s confirmed key policy positions at a glance
The Irish News· 18 hours agoThe new Government has acted with urgency as it seeks to make early progress on the big challenges...
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma...
Nature· 18 hours agoThe SAVE-MORE phase 3 study demonstrates the efficacy of anakinra, an IL-1α/β inhibitor, in patients with COVID-19 and high serum levels of soluble plasminogen activator receptor.
Long Island Compromise by Taffy Brodesser-Akner review – trials of the wealthy
The Guardian· 19 hours agoIt’s an instant connection, which shouldn’t be a surprise because this is New York Times journalist Taffy Brodesser-Akner, whose intelligent and supremely engaging debut, Fleishman Is in Trouble ...
